MEDICINOVA INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Medicinova Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Medicinova Inc Return On Equity for the quarter ending September 30, 2024 was -17.6 %, a 23.5% decline year-over-year.
  • Medicinova Inc annual Return On Equity for 2023 was -13.2 %, a 29.6% increase from 2022.
  • Medicinova Inc annual Return On Equity for 2022 was -18.7 %, a 62.7% decline from 2021.
  • Medicinova Inc annual Return On Equity for 2021 was -11.5 %, a 39.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -17.6 -3.34 -23.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -13.4 +4.65 +25.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -13.3 +5.57 +29.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -13.2 +5.55 +29.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -14.2 +2.56 +15.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -18 -2.03 -12.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18.9 -3.21 -20.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -18.7 -7.22 -62.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -16.8 -3.76 -28.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -16 -2.32 -17% Apr 1, 2022 Jun 30, 2022
Q1 2022 -15.7 -1 -6.81% Jan 1, 2022 Mar 31, 2022
Q4 2021 -11.5 +7.64 +39.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -13 +4.56 +26% Jul 1, 2021 Sep 30, 2021
Q2 2021 -13.7 +2.03 +12.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -14.7 +0.13 +0.88% Jan 1, 2021 Mar 31, 2021
Q4 2020 -19.2 -1.76 -10.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -17.6 -2.46 -16.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -15.7 +5.41 +25.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -14.8 +5.13 +25.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -17.4 +2.31 +11.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -15.1 +9.3 +38.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -21.1 +2.12 +9.12% Apr 1, 2019 Jun 30, 2019
Q1 2019 -20 +7.89 +28.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -19.7 +12.3 +38.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -24.4 +3.84 +13.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -23.2 -6.2 -36.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -27.8 -10.1 -57.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -32 -14.1 Oct 1, 2017 Dec 31, 2017
Q3 2017 -28.3 -10.1 Jul 1, 2017 Sep 30, 2017
Q2 2017 -17 +1.27 +6.94% Apr 1, 2017 Jun 30, 2017
Q1 2017 -17.7 -7 -65.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -17.9* -17.9 Oct 1, 2016 Dec 31, 2016
Q3 2016 -18.2* -18.1 Jul 1, 2016 Sep 30, 2016
Q2 2016 -18.3 -18.3 Apr 1, 2016 Jun 30, 2016
Q1 2016 -10.7 -10.7 Jan 1, 2016 Mar 31, 2016
Q4 2015 -0.03* +0.01 Oct 1, 2015 Dec 31, 2015
Q3 2015 -0.03* -13.7 Jul 1, 2015 Sep 30, 2015
Q2 2015 -0.04* -4.81 Apr 1, 2015 Jun 30, 2015
Q1 2015 -0.04* +6.65 Jan 1, 2015 Mar 31, 2015
Q4 2014 -0.04* +19.1 Oct 1, 2014 Dec 31, 2014
Q3 2014 13.6* +67.4 Jul 1, 2014 Sep 30, 2014
Q2 2014 4.77* +63 Apr 1, 2014 Jun 30, 2014
Q1 2014 -6.69* +53.1 Jan 1, 2014 Mar 31, 2014
Q4 2013 -19.2 +43.4 +69.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -53.7 +7.46 +12.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -58.3 +8.46 +12.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -59.7 +14.4 +19.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -62.6 Oct 1, 2012 Dec 31, 2012
Q3 2012 -61.2 Jul 1, 2012 Sep 30, 2012
Q2 2012 -66.7 Apr 1, 2012 Jun 30, 2012
Q1 2012 -74.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.